Skip to main content

Table 3 Distribution of the population and MST for each PI

From: Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram

PI Number of patients % MST (months) p value
RPA    15 <0.001
 I 79 35.4 27 <0.001
 II 118 52.9 13 0.144
 III 26 11.7 8  
SIR    15 <0.001
 I 33 14.8 33 0.003
 II 164 73.5 15 0.003
 III 26 11.7 9  
BS-BM    15 <0.001
 I 27 12.1 5 0.036
 II 63 28.3 11 <0.001
 III 74 33.2 18 0.001
 IV 59 26.4 31  
GGS    15 0.001
 I 106 47.5 21 0.058
 II 87 39.0 14 0.631
 III 25 11.2 12 0.054
 IV 5 2.3 5  
DS-GPA    15 0.003
 I 27 12.1 11 0.799
 II 68 30.5 14 0.261
 III 100 44.8 15 0.003
 IV 28 12.6 37  
NSCLC-RADES    15 <0.001
 I 66 29.6 11 0.025
 II 103 46.2 16 0.002
 III 54 24.2 27